|
|
|||
|
|
|||
|
HOME |
|||
|
|
|||
|
AriaVax, Inc. |
|
| |
|
AriaVax, Inc. is a research stage biotechnology company that develops novel vaccines for a variety of diseases. AriaVax vaccines are based on its proprietary peptide chemistry technology exclusively licensed by the Company from The National Institutes of Health. This technology allows the development of vaccines that selectively and specifically generate effective antibody-inducing immune responses against previously inaccessible critical segments of viral or bacterial proteins, or the cellular proteins to which these pathogens attach. |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||
